Center-Authored Papers

Filters: Author is Song, Yoon Ju  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Weight Gain
Song YJ, Tangen CM, Goodman P, Parnes HL, Lucia SM, Thompson IM, Kristal AR.  2008.  Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.. The Prostate. 68(3):281-6. Abstract
Washington
Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA.  2008.  Coffee, tea, colas, and risk of epithelial ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(3):712-6. Abstract
United States
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
Treatment Outcome
Song YJ, Tangen CM, Goodman P, Parnes HL, Lucia SM, Thompson IM, Kristal AR.  2008.  Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.. The Prostate. 68(3):281-6. Abstract
Time Factors
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
Tea
Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA.  2008.  Coffee, tea, colas, and risk of epithelial ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(3):712-6. Abstract
Shared Resources
Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA.  2008.  Coffee, tea, colas, and risk of epithelial ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(3):712-6. Abstract
Sex Hormone-Binding Globulin
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
Risk Factors
Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA.  2008.  Coffee, tea, colas, and risk of epithelial ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(3):712-6. Abstract
Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR.  2008.  Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.. The Prostate. 68(13):1477-86. Abstract
Risk Assessment
Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA.  2008.  Coffee, tea, colas, and risk of epithelial ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(3):712-6. Abstract
Retrospective Studies
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
Questionnaires
Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA.  2008.  Coffee, tea, colas, and risk of epithelial ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(3):712-6. Abstract
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
Public Health Sciences Division
Song YJ, Tangen CM, Goodman P, Parnes HL, Lucia SM, Thompson IM, Kristal AR.  2008.  Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.. The Prostate. 68(3):281-6. Abstract
Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR.  2008.  Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.. The Prostate. 68(13):1477-86. Abstract
Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA.  2008.  Coffee, tea, colas, and risk of epithelial ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(3):712-6. Abstract
Prostatic Neoplasms
Song YJ, Tangen CM, Goodman P, Parnes HL, Lucia SM, Thompson IM, Kristal AR.  2008.  Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.. The Prostate. 68(3):281-6. Abstract
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR.  2008.  Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.. The Prostate. 68(13):1477-86. Abstract
Prostatic Hyperplasia
Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR.  2008.  Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.. The Prostate. 68(13):1477-86. Abstract
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
Prognosis
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
Prevalence
Kristal AR, Schenk JM, Song YJ, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.  2008.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 168(12):1416-24. Abstract
Predictive Value of Tests
Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR.  2008.  Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.. The Prostate. 68(13):1477-86. Abstract